ABT-199 (GDC-0199) in relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL): High complete-response rate and durable disease control Meeting Abstract


Authors: Seymour, J. F.; Davids, M. S.; Pagel, J. M.; Kahl, B. S.; Wierda, W. G.; Puvvada, S.; Gerecitano, J. F.; Kipps, T. J.; Anderson, M. A.; Huang, D. C. S.; Rudersdorf, N.; Gressick, L. A.; Montalvo, N. P.; Yang, J. N.; Zhu, M.; Dunbar, M.; Cerri, E.; Enschede, S. H.; Humerickhouse, R.; Roberts, A. W.
Abstract Title: ABT-199 (GDC-0199) in relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL): High complete-response rate and durable disease control
Meeting Title: 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15 Suppl.
Meeting Dates: 2014 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Language: English
ACCESSION: WOS:000358613203833
PROVIDER: wos
DOI: 10.1200/jco.2014.32.15_suppl.7015
Notes: Meeting Abstract: 7015 -- Source: Wos
Altmetric
Citation Impact
MSK Authors